Evaluating the Effect of Utrogestan on Idiopathic Intrauterine Growth Retardation
| Autor: | Marzieh Matinfar, Fatemeh Drees, Belgheis Mohammadi, Sheida Shabanian |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
utrogestan Utrogestan placenta Obstetrics business.industry lcsh:R Therapeutic effect lcsh:Medicine Gestational age Umbilical artery General Medicine Clinical trial Fetal growth retardation Exact test medicine.anatomical_structure lcsh:Biology (General) Placenta medicine.artery medicine Apgar score Original Article business lcsh:QH301-705.5 |
| Zdroj: | Advanced Biomedical Research Advanced Biomedical Research, Vol 9, Iss 1, Pp 45-45 (2020) |
| ISSN: | 2277-9175 |
| Popis: | Background: Intrauterine growth factor (IUGR) is one of the most important causes of neonatal mortality. The aim of this study was to evaluate the therapeutic effect of utrogestan on the treatment of IUGR and its complications. Materials and Methods: In this clinical trial, 66 pregnant women with idiopathic IUGR embryos were enrolled. Patients in the intervention group, in addition to receiving routine treatment of control group (high-protein diet, resting), took utrogestan capsules (100 mg) twice daily. The primary and secondary outcomes of the disease were recorded in a checklist. Data were analyzed using SPSS 18 using an independent t-test, Chi-square test, and Fisher's exact test. Results: In the intervention group, mean neonatal weight (P = 0.003), mean neonatal Apgar score (P = 0.001), and mean gestational age at birth (P = 0.001) were significantly higher than those in the control group. There was no neonatal death in the intervention group, whereas in the control group, four cases of neonatal death were observed (P = 0.03). In the majority of subjects in the intervention group, resistance index, and pulsatility index of the umbilical artery decreased (P = 0.002). The difference in abdominal circumference and gestational age in the intervention group decreased (P = 0.01). In the intervention group, the diastolic flow of the umbilical artery increased (P = 0.002). Conclusion: Utrogestan was effective as an inexpensive and effective way to treat IUGR and improve pregnancy outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|